Cargando…
Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report
INTRODUCTION: Contrast-induced encephalopathy represents a rare, reversible complication that appears after intravenous or intra-arterial exposure to contrast agents. There is no consensus in the literature regarding the mechanism of action. However, the theoretical mechanism is set around the disru...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519365/ https://www.ncbi.nlm.nih.gov/pubmed/34722917 http://dx.doi.org/10.2478/jccm-2021-0010 |
_version_ | 1784584432512925696 |
---|---|
author | Andone, Sebastian Balasa, Rodica Barcutean, Laura Bajko, Zoltan Ion, Valentin Motataianu, Anca Stoian, Adina Maier, Smaranda |
author_facet | Andone, Sebastian Balasa, Rodica Barcutean, Laura Bajko, Zoltan Ion, Valentin Motataianu, Anca Stoian, Adina Maier, Smaranda |
author_sort | Andone, Sebastian |
collection | PubMed |
description | INTRODUCTION: Contrast-induced encephalopathy represents a rare, reversible complication that appears after intravenous or intra-arterial exposure to contrast agents. There is no consensus in the literature regarding the mechanism of action. However, the theoretical mechanism is set around the disruption of the blood-brain barrier and the contrast agents’ chemical properties. CASE REPORT: The case of a 70-year-old patient, known to have hypertension and type 2 diabetes mellitus is reported. The patient had undergone a diagnostic coronary angiography during which he received 100ml of Ioversol (Optiray 350™). Soon after the procedure, the patient began experiencing a throbbing headache, followed by intense behavioural changes and aggressive tendencies. He was transferred to the Neurology Clinic. The neurological examination was without focal neurological signs; however, the patient was very aggressive and uncooperative. The CT scan revealed a mild hyper-density in the frontal lobes. MRI scan revealed no pathological changes. Conservative treatment with diuretics and hydration was administered, and the patient experienced a complete resolution of symptoms in 72 hours. CONCLUSION: Contrast-induced encephalopathy is a possible secondary complication to contrast agents and a diagnostic challenge, and it should not be overlooked, especially following procedures that use contrast agents. |
format | Online Article Text |
id | pubmed-8519365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Sciendo |
record_format | MEDLINE/PubMed |
spelling | pubmed-85193652021-10-28 Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report Andone, Sebastian Balasa, Rodica Barcutean, Laura Bajko, Zoltan Ion, Valentin Motataianu, Anca Stoian, Adina Maier, Smaranda J Crit Care Med (Targu Mures) Case Report INTRODUCTION: Contrast-induced encephalopathy represents a rare, reversible complication that appears after intravenous or intra-arterial exposure to contrast agents. There is no consensus in the literature regarding the mechanism of action. However, the theoretical mechanism is set around the disruption of the blood-brain barrier and the contrast agents’ chemical properties. CASE REPORT: The case of a 70-year-old patient, known to have hypertension and type 2 diabetes mellitus is reported. The patient had undergone a diagnostic coronary angiography during which he received 100ml of Ioversol (Optiray 350™). Soon after the procedure, the patient began experiencing a throbbing headache, followed by intense behavioural changes and aggressive tendencies. He was transferred to the Neurology Clinic. The neurological examination was without focal neurological signs; however, the patient was very aggressive and uncooperative. The CT scan revealed a mild hyper-density in the frontal lobes. MRI scan revealed no pathological changes. Conservative treatment with diuretics and hydration was administered, and the patient experienced a complete resolution of symptoms in 72 hours. CONCLUSION: Contrast-induced encephalopathy is a possible secondary complication to contrast agents and a diagnostic challenge, and it should not be overlooked, especially following procedures that use contrast agents. Sciendo 2021-05-12 /pmc/articles/PMC8519365/ /pubmed/34722917 http://dx.doi.org/10.2478/jccm-2021-0010 Text en © 2021 Sebastian Andone, Rodica Balasa, Laura Barcutean, Zoltan Bajko, Valentin Ion, Anca Motataianu, Adina Stoian, Smaranda Maier, published by Sciendo https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Case Report Andone, Sebastian Balasa, Rodica Barcutean, Laura Bajko, Zoltan Ion, Valentin Motataianu, Anca Stoian, Adina Maier, Smaranda Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report |
title | Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report |
title_full | Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report |
title_fullStr | Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report |
title_full_unstemmed | Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report |
title_short | Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report |
title_sort | contrast medium-induced encephalopathy after coronary angiography– case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519365/ https://www.ncbi.nlm.nih.gov/pubmed/34722917 http://dx.doi.org/10.2478/jccm-2021-0010 |
work_keys_str_mv | AT andonesebastian contrastmediuminducedencephalopathyaftercoronaryangiographycasereport AT balasarodica contrastmediuminducedencephalopathyaftercoronaryangiographycasereport AT barcuteanlaura contrastmediuminducedencephalopathyaftercoronaryangiographycasereport AT bajkozoltan contrastmediuminducedencephalopathyaftercoronaryangiographycasereport AT ionvalentin contrastmediuminducedencephalopathyaftercoronaryangiographycasereport AT motataianuanca contrastmediuminducedencephalopathyaftercoronaryangiographycasereport AT stoianadina contrastmediuminducedencephalopathyaftercoronaryangiographycasereport AT maiersmaranda contrastmediuminducedencephalopathyaftercoronaryangiographycasereport |